Literature DB >> 14671028

Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction.

Liffert Vogt1, Gozewijn D Laverman, Robin P F Dullaart, Gerjan Navis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14671028     DOI： 10.1093/ndt/gfg497

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

1.  Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting.

Authors:  BinBin Zheng-Lin; Alberto Ortiz
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

2.  Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome.

Authors:  Lagu He; Pengfei Wu; Li Tan; Bai Le; Wenhan Du; Ting Shen; Jiali Wu; Zheyi Xiang; Min Hu
Journal:  Lipids Health Dis       Date:  2017-09-06       Impact factor: 3.876

3.  Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy.

Authors:  Anand Srivastava; Beverley Adams-Huet; Gloria L Vega; Robert D Toto
Journal:  J Investig Med       Date:  2016-07-07       Impact factor: 2.895
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.